unsolicited acquisition bid

Qiagen has submitted an offer to buy all of Exiqon's shares for DKK18 each, for a total aggregate purchase price of DKK683 million ($103.5 million).

NEW YORK (GenomeWeb News) – A filing by Complete Genomics with the US Securities and Exchange Commission Wednesday suggests that another firm may be interested in entering the bidding to acquire the firm.

NEW YORK (GenomeWeb News) – Complete Genomics has again rejected Illumina's approach to acquire the firm.

NEW YORK (GenomeWeb News) – BGI-Shenzhen today said that it has extended its offer to acquire Complete Genomics for around $118 million until midnight New York City time on Dec. 14.

NEW YORK (GenomeWeb News) – Illumina confirmed that it made a competing unsolicited bid for Complete Genomics at about 5 percent above BGI-Shenzhen's offer for the Mountain View, Calif.-based next-generatio

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.